AI devices with FDA product code QDQ — Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

Product code QDQ (“Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer” in openFDA) covers 36 devices on the FDA AI-enabled list, from 18 companies. Most are reviewed by the Radiology panel (36). The most recent decision was MammoScreen® (5) on June 26, 2026.